Need Help?

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer

The utility of circulating tumour DNA (ctDNA) for longitudinal tumour monitoring in pancreatic ductal adenocarcinoma (PDAC) has not been explored beyond mutations in the KRAS proto-oncogene. We aim to characterise and track patient-specific somatic ctDNA variants, to assess longitudinal changes in disease burden and explore the landscape of actionable alterations.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001008593 Illumina HiSeq 4000 Illumina NovaSeq 6000 34
Publications Citations
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
BMC Cancer 22: 2022 369
7